Abbott, medical devices and health care company headquartered in Abbott Park, Illinois, has issued a recall for three of its leading baby formulas, including Similac, Alimentum, and EleCare. The recall was due to the discovery of cases where infants fell ill after consuming the milk brands.
According to Fox Business, the cases involve four infants in three states - Ohio, Texas, and Minnesota. The U.S. Food and Drug Administration stated that the powdered milk for infants was manufactured in Abbott Nutrition's Sturgis, Michigan facility.
The FDA is investigating the four cases that caused Cronobacter sakazakii and Salmonella Newport infections in the said regions. The babies were said to have been hospitalized, and there was one case of death where the FDA suspects that the Cronobacter may have contributed to the unfortunate incident.
In its recall announcement, the agency, along with U.S. Centers for Disease Control and Prevention, have warned and advised the public to refrain from buying certain Abbott powdered baby formulas that were made at the Sturgis, Michigan plant. It also mentioned that the investigation is still ongoing.
Moreover, the FDA is informing everyone to discard Similac, Alimentum, and EleCare baby milk formulas if the first two digits of the code are 22 to 37 and if the code on the container shows K8, SH, or Z2. The expiration date of the affected milk is April 1, 2022, or later.
At any rate, Abbott voluntarily recalled the affected products after receiving four complaints from the consumers. Then again, the company stressed that the recall is an isolated case and only affects powder formulas - Similac, Alimentum, and EleCare - that were made at its Sturgis, Michigan plant. The company further said that the liquid formulas or other Abbott nutrition powders are not included in the recall.
"We know parents depend on us to provide them with the highest quality nutrition formulas," Abbott's executive vice president, nutritional products, Joe Manning, said in a press release. "We are taking this action so parents know they can trust us to meet our high standards, as well as theirs. We deeply regret the concern and inconvenience this situation will cause parents, caregivers, and health care professionals."
Finally, the FDA Deputy Commissioner for Food Policy and Response, Frank Yiannas, said they are working to solve the safety concerns as soon as possible as they are aware of the severity of the issue.


Gold Prices Slip Slightly in Asia as Silver Nears Record Highs on Dovish Fed Outlook
Asian Stocks Slip as Oracle Earnings Miss Sparks AI Profitability Concerns
Coca-Cola’s Costa Coffee Sale Faces Uncertainty as Talks With TDR Capital Hit Snag
Asian Currencies Steady as Fed Delivers Hawkish Rate Cut; Aussie and Rupee Under Pressure
Japan Weighs New Tax Breaks to Boost Corporate Investment Amid Spending Debate
ANZ Faces Legal Battle as Former CEO Shayne Elliott Sues Over A$13.5 Million Bonus Dispute
Nvidia Develops New Location-Verification Technology for AI Chips
BOJ Expected to Deliver December Rate Hike as Economists See Borrowing Costs Rising Through 2025
ADB Approves $400 Million Loan to Boost Ease of Doing Business in the Philippines
Asian Currencies Hold Steady as Indian Rupee Slides to Record Low on Fed Outlook
Fed’s Dovish Tone Sends Dollar Lower as Markets Price In More Rate Cuts
SoftBank Eyes Switch Inc as It Pushes Deeper Into AI Data Center Expansion
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs
Modi and Trump Hold Phone Call as India Seeks Relief From U.S. Tariffs Over Russian Oil Trade
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise
EU Court Cuts Intel Antitrust Fine to €237 Million Amid Long-Running AMD Dispute
Evercore Reaffirms Alphabet’s Search Dominance as AI Competition Intensifies 



